Transcription of C型肝炎治療的新選擇―― Sovaldi® …
{{id}} {{{paragraph}}}
13C Sovaldi Tablets sofosbuvir Harvoni Tablets Ledipasvir plus sofosbuvir Gilead Sciences C C HCV DAA Direct-acting antiviral agents 2 C [1-2] Sovaldi Tablets [3] 400 mg sofosbuvir Harvoni Tablets[4] 90 mg Ledipasvir 400 mg sofosbuvir 2 HCV HIV Sovaldi Tablets sofosbuvir sofosbuvir sofosbuvir GS-461203 HCV [1] HCV 132015/10/23 07:12:2914 92 <C Interferon free treatment strategy> PegInterferon Ribavirin RBV HCV HIV sofosbuvir RBV 12 24 sofosbuvir RBV 12 [5-8] [9-13] [14-15] sofosbuvir RBV sofosbuvir 400 mg Ribavirin RBV 12 24 [5-8] Study Name ( ) ( )SVR rate( %) HCV RNA <25 IU/mL ( %)2 4 12 Lawitz et al.
13 C型肝炎治療的新選擇―― Sovaldi® ®Tablets(Sofosbuvir)及 Harvoni®® Tablets(Ledipasvir plus Sofosbuvir)之介紹 謝思民
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}